Opposition turns up heat on health 'freebie' claims
News | 14 June 2012
Fresh evidence of "freebies" given to West Australian Health Department staff by pharmaceutical companies has emerged, with the state opposition labelling it ...
Click on the link to read the full article at Sydney Morning Herald
(This link will open in a new window)
- Alchemia and Merck Serono collaborate on HA-Irinotecan with Erbitux
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- US FDA advisory panel backs approval of Merck & Co's suvorexant, but only at lower doses
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Positive new data on Novartis' Galvus in elderly type 2 diabetes patients
